KLP Kapitalforvaltning AS Invests $337,000 in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)

KLP Kapitalforvaltning AS bought a new position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 24,200 shares of the company’s stock, valued at approximately $337,000. A number of other institutional investors have also recently added to or reduced their stakes in ARQT. Point72 […]